Lorence H. Kim, Chief Financial Officer at Moderna, Inc. (MRNA), sold 37,907 shares at $28.79 ($1.1M) on 2020-02-26, disclosed to the SEC on 2020-02-27.
Open-market sale of $1.1M MRNA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.59 | 1,248 | $32K | 3.0% |
| 2 | $26.14 | 100 | $3K | 0.2% |
| 3 | $27.96 | 5,088 | $142K | 13.2% |
| 4 | $27.96 | 5,088 | $142K | 13.2% |
| 5 | $28.79 | 12,819 | $369K | 34.2% |
| 6 | $28.79 | 12,819 |
| $369K |
| 34.2% |
| 7 | $29.46 | 745 | $22K | 2.0% |
| Total | $28.47 avg | 37,907 | $1.1M | 100% |
| Filing → |
| RVMD | BUY | 2022-07-25 | $1.0M | — | Filing → |
| COWN | BUY | 2022-02-28 | $901K | — | Filing → |
| MRNA | SELL | 2020-06-04 | $14.1M | — | Filing → |